Clinical trial
A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia…
NCT00127179 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00127179 |
|---|---|
| Title | A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) |
| Official title | MK0906 Phase III Double-Blind Comparative Study - Benign Prostate Hyperplasia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Benign Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | MK0906, finasteride / Duration of Treatment: 48 weeks, Comparator: placebo / Duration of Treatment: 48 weeks |
| Enrollment | 600 |
| Start date | Jan 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 25, 2005 |
| First posted | Aug 5, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: